We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
GUTS icon
126
Fractyl Health
GUTS
$60M
$60M $4.52 1.09%
CNTB
127
Connect Biopharma Holdings
CNTB
$59.5M
$59.5M $0.9447 4.34%
XLO icon
128
Xilio Therapeutics
XLO
$59.3M
$59.3M $9.01 0.11%
INKT icon
129
MiNK Therapeutics
INKT
$58.3M
$58.3M $11.42 2.39%
ACET icon
130
Adicet Bio
ACET
$57.9M
$57.9M $6.18 1.12%
ALDX icon
131
Aldeyra Therapeutics
ALDX
$57.8M
$57.8M $0.9586 4.66%
ALPS
132
ALPS Group Inc
ALPS
$57.3M
$57.3M $0.3444 10.7%
MREO
133
Mereo BioPharma
MREO
$56.3M
$56.3M $0.3528 0.77%
LONA
134
LeonaBio Inc
LONA
$54.9M
$54.9M $5.83 1.39%
HYPD
135
Hyperion DeFi Inc
HYPD
$54.6M
$54.6M $3.59 6.02%
IMA
136
ImageneBio Inc
IMA
$52.3M
$52.3M $4.61 0.22%
ANVS icon
137
Annovis Bio
ANVS
$51.6M
$51.6M $1.21 2.54%
INMB icon
138
INmune Bio
INMB
$51.6M
$51.6M $1.86 0.53%
EXOZ
139
eXoZymes Inc
EXOZ
$51.5M
$51.5M $5.54 0.36%
ELOX
140
Eloxx Pharmaceuticals
ELOX
$51.1M
$51.1M $14.88 1.65%
ELTX icon
141
Elicio Therapeutics
ELTX
$48.6M
$48.6M $1.85 1.6%
DWTX
142
Dogwood Therapeutics
DWTX
$48.6M
$48.6M $1.43 5.92%
CRVO icon
143
CervoMed
CRVO
$48.1M
$48.1M $3.18 4.79%
CELU icon
144
Celularity
CELU
$47.7M
$47.7M $1.47 6.96%
TIL icon
145
Instil Bio
TIL
$46.8M
$46.8M $6.90 0.15%
HOWL icon
146
Werewolf Therapeutics
HOWL
$44.7M
$44.7M $0.9201 0.01%
BSEM
147
BioStem Technologies
BSEM
$44.6M
$44.6M $2.39 3.24%
GRCE
148
Grace Therapeutics
GRCE
$44.2M
$44.2M $2.10 1.45%
TVGN icon
149
Tevogen Inc
TVGN
$42.3M
$42.3M $6.49 0%
VERU icon
150
Veru
VERU
$41.9M
$41.9M $2.46 0.4%
4 5
6
7 8

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 288 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $20.1B.

The largest by market cap are Immuneering (IMRX) at $250M, Nautilus Biotechnolgy (NAUT) at $249M and Vicore Pharma Holding AB ADS (VCRE) at $244M.

Among institutional investors, Eledon Pharmaceuticals (ELDN) drew the most net new fund positions in Q2 2026: 51 funds opened new positions, taking total fund holders up 40 (33%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.